Circulation Journal Vol. 66, October 2002 normal. Ultrasonic cardiogram (UCG) showed normal valves, normal left ventricular chamber size without pericardial effusion, and diffuse reduced wall motion. She was stabilizeded with an intra-aortic balloon pump (IABP) and a percutaneous cardiopulmonary support (PCPS) system, and coronary angiography (CAG) and left ventriculography (LVG) was then performed (Fig 2) . No significant stenosis in the coronary arteries was observed. LVG detected diffuse, reduced wall motion except in the anterobasal and posterobasal areas, and the left ventricular ejection fraction (LVEF) was 18%. These findings suggested fulminant myocarditis, and we initiated immunoglobulin (Venoglobulin-IH, Welfide Corporation, Japan) treatment (1 g·kg -1 ·day -1 ) on the 2nd hospital day for 2 days. After the treatment, the leukocyte count was decreased, and UCG showed recovery of wall motion on the 3rd hospital day (Fig 3) . The PCPS was removed on the 4th hospital day, and the IABP was removed on the 5th hospital day. On the 19th hospital day, cardiac catheterization with a left ventricular endomyocardial biopsy was performed. LVG showed improvement of global wall motion (LVEF 49%). The left ventricular endomyocardial biopsy revealed massive and multiple necrosis and degeneration of myocardial cells, and extensive infiltration of inflammatory cells ( Fig 4A,B) . The clinicopathology of this patient was thought to be fulminant myocarditis according to the criteria of Lieberman et al. 10 Measurement of neutralizing antibody titers in the paired samples for coxsackievirus and influenzavirus were performed, but no diagnostic elevation was observed. The patient's clinical course was satisfactory and she was discharged on the 29th hospital day.
Methods

Analysis for Serum TRX
The serum TRX was measured using a sandwich enzyme-linked immunosorbent assay (ELISA) kit (MBL) according to the procedure described previously. 11 After sample and blocking buffer containing 1% bovine serum albumin were incubated in ADF 21-antibody-precoated 96microwell plates, horseradish peroxidase-labeled anti-ADF 21 antibody was added. After substrate solution containing 2,2-azino-di-3-ethyl-benzthiazoline sulfonic acid was incubated, stopping solution (1% oxalic acid) was added. The absorption at 405 nm was measured with an ELISA reader (Molecular Devices, Menlo Park, CA, USA). Data were analyzed by a software SOFTmax Version 2.31 (Molecular Devices). In this protocol, the normal TRX levels were 14.0±4.6 ng/ml (mean ± SD). 11 
Immunohistochemistry for TRX in the Endomyocardial Biopsy Samples
Immunohistochemistry for TRX was performed as previously described. 8 Briefly, after paraffin sections of the heart were deparaffinized, endogenous peroxidase activity was inactivated with 3% H2O2, and normal goat serum was added for the inhibition of nonspecific binding of second antibody. The sections were incubated with the primary antibody (mouse anti-human ADF 21 antibody) and then with peroxidase-conjugated goat anti-mouse second antibody, and the color was developed with the substrate 0.1% 3',3'-diaminobenzidine, followed by hematoxylin nuclear counterstaining. For negative controls, sections were processed through all steps of the immunohistochemical staining without primary antibody. Table 1 shows the serial changes of TRX. The serum TRX level on the 2nd hospital day was already elevated and was unchanged by the immunoglobulin treatment; it was still elevated on the 20th hospital day. On the 116th hospital day, the serum TRX level decreased, but did not Immunohistochemistry for TRX in the biopsied myocardium of the left ventricle on the 20th hospital day showed that the inflammatory cells and cardiomyocytes were positively stained (Fig 4C,D) .
Results
Discussion
Myocarditis is an important cause of heart failure among adolescents and young adults and frequently precedes the development of dilated cardiomyopathy (DCM). Immune or autoimmune mechanisms may be involved in the myocarditis and subsequent cardiomyopathy, 1,12 but immunosuppressive therapy has not been shown to be beneficial in most patients with biopsy-proven myocarditis 2 and there is as yet no general agreement on effective treatment for acute myocarditis. Immunomodulatory therapy with highdose immunoglobulin has been reported for inflammatory and autoimmune diseases, 13 and has been reported as effective for acute myocarditis. 6, 7 We previously reported that immunoglobulin therapy suppressed acute viral myocarditis by an anti-viral effect, an anti-inflammatory effect and improvement in extracellular matrix changes. 14, 15 Moreover, immunoglobulin therapy suppressed experimental giant cell myocarditis in rats associated with the suppression of the expression of dendritic cell via inhibitory Fc receptor. 16 Because the leukocyte count was immediately decreased by the treatment, anti-inflammatory effects of immunoglobulin were shown in this study and, moreover, it may be because of the immunomodulatory effects of immunoglobulin that the patient's condition rapidly recov-ered, as spontaneous recovery of cardiac functions is in general slow in patients with acute myocarditis. 1, 17 Increasing evidence supports the role of local and systemic oxidative stresses in the development and severity of myocarditis and cardiomyopathy. 8, 18 Excessive production of reactive oxygen species (ROS) at the inflammatory site contributes to the inflammatory process by inducing the expression of adhesion molecules, proinflammatory cytokines, and chemoattractants. ROS scavengers, such as superoxide dismutase, have therapeutic potential for myocarditis. 19 TRX is a multifunctional protein that has a redoxactive disulfide/dithiol within the conserved active site sequence: Cys-Gly-Pro-Cys. TRX extracellularly shows cytoprotective activities against oxidative stresses, and intracellularly regulates protein -nucleic acid interactions through the regulation of the various gene expression via the redox factor-1. 9 In the present patient, the serum TRX level was high on the 20th hospital day, and had decreased, but not normalized on the 116th hospital day. However, the LVEF had already improved on the 19th hospital day and the leukocyte count also had normalized. The serum troponin T level on the 116th hospital day was less than 0.01 ng/dl, which did not suggest sustained myocarditis. Oxidative stresses persisted irrespective of the recovery of cardiac function and systemic inflammation, because the serum TRX level is a marker of oxidative stress. 9, 11, 20, 21 Why did the discrepancy between the serum TRX levels and the clinical course occur? One of reason is that the response to oxidative stresses may be delayed, as previously described in patients with burn injury. 21 TRX was positively stained in the inflammatory cells and myocytes in the biopsied myocardium and, therefore, one of the sources of serum TRX might be damaged cardiomyocytes during the acute phase. In addition, systematic release of TRX may continue even during the chronic phase, because the levels of TRX were constantly high, which indicates a higher rate of release than elimination by cellular uptake, degradation, or clearance in the urine.
In conclusion, we report a patient with fulminant myocarditis who was successfully treated with immunoglobulin and in whom we analyzed the serial serum levels of TRX and its myocardial immunohistochemistry. Further studies on a large number of patients using endomyocardial biopsy samples and quantitative parameters, such as troponin T and brain natriuretic peptide, are required to determine the association between TRX levels and clinicopathology in acute myocarditis. However, these findings may yield important insights into the redox regulating mechanism in the pathogenesis of acute myocarditis. 
